TGA

Medical devices have been become more important in the health care sector. It is mostly used for diagnosis and prevention of public health. There are more than 8000 generic medical device groups, where some medical devices contain drugs. This increases the demand for better regulatory frameworks to ensure that products entering in the market are safe as well as efficient. One of the major issues for companies developing and producing medical devices is to be updated on the bases of regulatory requirements and to implement them in the process. This is particularly true in developing countries, where assessments of health technology are rare and where little regulatory controls exist to prevent the importation or use of substandard devices. So regulation of medical device is a vital need in Pharmaceutical Sector. This article mainly focuses on classification, classification rules, registration procedure, documents required for registration of medical device and fees for application of medical devices in Australia and India. In Australia medical devices are regulated by Therapeutics Good Administration (TGA) whereas in India medical devices are regulated by Central Drugs Standard Control Organization (CDSCO).

The present study aims at investigating the different combinations of polymers with inclusion complex of Carvedilol (CR)-Hydroxypropyl betacyclodextrin (HPβCD) prepared in a ratio of 1:1 by use of various analytical techniques like Fourier Transformation Infrared spectroscopy (FTIR), X-ray diffraction technique (XRD), Digital scanning calorimetry (DSC), Thermo gravimetric analysis (TGA) as a part of preformulation studies. Various polymers used for the present study were Sodium alginate (SA), Hydroxy propyl beta cyclodextrin (HPBCD), Hydroxy propyl methyl cellulose LV E-15(HPMC), Pectin (P), Eudragit NE30D (EU). This study indicated that Carvedilol formed inclusion complex with the HPβCD, but in combination with other polymers, drug did not show any other interactions.